BALDWIN BROTHERS LLC/MA - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 63 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.4%.

Quarter-by-quarter ownership
BALDWIN BROTHERS LLC/MA ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$6,145
+7.2%
5000.0%0.00%0.0%
Q4 2022$5,730
+186.5%
5000.0%0.00%
Q3 2022$2,000
-33.3%
5000.0%0.00%
Q2 2022$3,0000.0%5000.0%0.00%
Q1 2022$3,000
+50.0%
5000.0%0.00%
Q4 2021$2,0000.0%5000.0%0.00%
Q3 2021$2,000
-33.3%
5000.0%0.00%
Q2 2021$3,0000.0%5000.0%0.00%
Q1 2021$3,0000.0%5000.0%0.00%
Q4 2020$3,000
+50.0%
5000.0%0.00%
Q3 2020$2,0000.0%5000.0%0.00%
Q2 2020$2,000
+100.0%
5000.0%0.00%
Q1 2020$1,000
-50.0%
5000.0%0.00%
Q4 2019$2,0000.0%5000.0%0.00%
Q3 2019$2,000
-33.3%
5000.0%0.00%
Q2 2019$3,0000.0%5000.0%0.00%
Q1 2019$3,000
+50.0%
5000.0%0.00%
Q4 2018$2,000
-33.3%
5000.0%0.00%
Q3 2018$3,000
+50.0%
5000.0%0.00%
Q2 2018$2,000
-50.0%
5000.0%0.00%
-100.0%
Q1 2018$4,0005000.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
Newtyn Management, LLC 633,297$3,109,0000.58%
BVF INC/IL 1,110,588$5,453,0000.53%
WITTENBERG INVESTMENT MANAGEMENT, INC. 253,752$1,246,0000.53%
Rubric Capital Management LP 476,164$2,338,0000.23%
Clearline Capital LP 59,331$291,0000.19%
Yakira Capital Management, Inc. 66,934$329,0000.08%
KEMPNER CAPITAL MANAGEMENT INC. 14,898$73,0000.05%
STONEBRIDGE CAPITAL MANAGEMENT INC 20,725$106,0000.04%
J. Goldman & Co LP 100,000$491,0000.02%
Dynamic Technology Lab Private Ltd 22,731$112,0000.02%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders